BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22481460)

  • 1. Living Fasciola hepatica in biliary tree: a case report.
    Aminian K; Rezayat KA; Shafaghi A; Tanhaeevash R
    Ann Hepatol; 2012; 11(3):395-8. PubMed ID: 22481460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasciola hepatica-a "Diver" in the Biliary Tree.
    Martins A; Gonçalves Á; Almeida T; Lopes L; Midões A
    J Gastrointest Surg; 2017 Nov; 21(11):1959-1960. PubMed ID: 28634648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoclinic.
    Ashjaei B; Farahmand F; Vasei M; Zamani F; Haghi Ashtiani MT; Moradzadeh A; Safavi M
    Arch Iran Med; 2020 Jun; 23(6):412-413. PubMed ID: 32536180
    [No Abstract]   [Full Text] [Related]  

  • 4. An incidental case of biliary fascioliasis mimicking cholangiocellular carcinoma.
    Şenateş E; Doğan A; Şenates BE; Bodakçi E; Bekçibasi M
    Infez Med; 2014 Dec; 22(4):313-6. PubMed ID: 25551848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical presentation and management of Fasciola hepatica infection: single-center experience.
    Kaya M; Beştaş R; Cetin S
    World J Gastroenterol; 2011 Nov; 17(44):4899-904. PubMed ID: 22171131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic mass caused by Fasciola hepatica: a tricky differential diagnosis.
    Yilmaz B; Köklü S; Gedikoglu G
    Am J Trop Med Hyg; 2013 Dec; 89(6):1212-3. PubMed ID: 24080633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical presentation of a very rare infection: parenchymal Fasciola hepatica.
    Sapmaz F; Kalkan IH; Guliter S; Nazlıoğlu A
    Turkiye Parazitol Derg; 2013; 37(4):305-6. PubMed ID: 24412878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic endoscopic retrograde cholangiopancreatography for the treatment of Fasciola hepatica presenting as biliary obstruction.
    Fullerton JK; Vitale M; Vitale GC
    Surg Innov; 2006 Sep; 13(3):179-82. PubMed ID: 17056782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatobiliary fasciolasis without eosinophilia].
    Gil Gil F; Cervero Jiménez M; Torres Perea R; Jusdado Ruiz-Capillas JJ
    Rev Clin Esp; 2006 Oct; 206(9):464. PubMed ID: 17042995
    [No Abstract]   [Full Text] [Related]  

  • 10. Imported Fasciola hepatica infection in the United States and treatment with triclabendazole.
    Graham CS; Brodie SB; Weller PF
    Clin Infect Dis; 2001 Jul; 33(1):1-5. PubMed ID: 11389487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoscopic removal by ERCP of Fasciola hepatica alive: two case reports and review of the literature].
    Lazo Molina L; Garrido Acedo R; Cárdenas Ramírez B; Torreblanca Nava J
    Rev Gastroenterol Peru; 2013; 33(1):75-81. PubMed ID: 23539060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy and tolerability of triclabendazole in Cuban patients with latent and chronic Fasciola hepatica infection.
    Millán JC; Mull R; Freise S; Richter J;
    Am J Trop Med Hyg; 2000; 63(5-6):264-9. PubMed ID: 11421375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fascioliasis: sonographic abnormalities of the biliary tract and evolution after treatment with triclabendazole.
    Richter J; Freise S; Mull R; Millán JC
    Trop Med Int Health; 1999 Nov; 4(11):774-81. PubMed ID: 10588772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance of Fasciola hepatica to triclabendazole.
    Overend DJ; Bowen FL
    Aust Vet J; 1995 Jul; 72(7):275-6. PubMed ID: 8534235
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficacy of triclabendazole against Fasciola hepatica in the donkey (Equus asinus).
    Trawford AF; Tremlett JG
    Vet Rec; 1996 Aug; 139(6):142-3. PubMed ID: 8863404
    [No Abstract]   [Full Text] [Related]  

  • 16. Education and imaging. Hepatobiliary and pancreatic: fascioliasis.
    Karabuli TA; Shaikhani MA; Karadaghi SH; Kasnazan KH
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1309. PubMed ID: 19682202
    [No Abstract]   [Full Text] [Related]  

  • 17. Fascioliasis: 3 cases with three different clinical presentations.
    Arslan F; Batirel A; Samasti M; Tabak F; Mert A; Özer S
    Turk J Gastroenterol; 2012 Jun; 23(3):267-71. PubMed ID: 22798118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of a restricted programme of strategic dosing against Fasciola hepatica with triclabendazole.
    Fawcett AR
    Vet Rec; 1990 Nov; 127(20):492-3. PubMed ID: 2275087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biliary obstruction caused by the liver fluke, Fasciola hepatica.
    Ishikawa T; Meier-Stephenson V; Heitman SJ
    CMAJ; 2016 Apr; 188(7):524-526. PubMed ID: 26728843
    [No Abstract]   [Full Text] [Related]  

  • 20. A pediatric case of Fascioliasis with eosinophilic pneumonia.
    Bayhan Gİ; Batur A; Taylan-Özkan A; Demirören K; Beyhan YE
    Turk J Pediatr; 2016; 58(1):109-112. PubMed ID: 27922247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.